Guidewire Software (GWRE) Reports Solid 1Q Earnings; UBS Raises Price Target to $70
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
- S&P 500 falls as AI worries hit software makers
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- Harry and Meghan surprised by King Charles' letter on their status
- Citi initiates UiPath coverage with Buy rating and $23 target
- S&P 500 falls as AI worries hit software makers
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- After an 18% summer selloff in chip stocks, Citi asks what comes next
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
After-Hours Movers 12/01: (ONDK) (APIC) (ASNA) Higher; (OGXI) (POWL) (BOBE) Lower (more...)
December 1, 2015 5:54 PM ESTOncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) 32% LOWER; Following an independent Data Monitoring Committee (DMC) meeting, OncoGenex announced today that its Phase 3 AFFINITY trial is continuing based on the pre-planned interim futility analysis of the intent-to-treat (ITT) population. In the final safety review, no new safety issues were identified by the DMC. Both the DMC and OncoGenex remain blinded to all analyses and final results are expected in the second half of 2016, depending on timing of the event-driven final analysis. Separately, an analysis of a prospectively defined subpopulation of men... More
Guidewire Software (GWRE) Tops Q1 EPS by 4c
December 1, 2015 4:17 PM ESTGuidewire Software (NYSE: GWRE) reported Q1 EPS of $0.07, $0.04 better than the analyst estimate of $0.03. Revenue for the quarter came in at $82.3 million versus the consensus estimate of $81.43 million.
Guidewire Software sees Q2 2016 EPS of $0.13-$0.17, versus the consensus of $0.14. Guidewire Software sees Q2 2016... More
Trading Radar for 12/1: Scotiabank (BNS), Ascena Retail (ASNA), Ooma (OOMA), UTI (UTI) Report
November 30, 2015 2:57 PM ESTThe Trading Radar highlights key earnings and economic announcements for the next trading session:
Before Markets Open:
Earnings:
BMO Financial Group (NYSE: BMO) - consensus EPS $1.74
Bank of Nova Scotia (NYSE: BNS) - consensus... More
